Contribution of bacterial sepsis to morbidity in infants born to HIV-infected Haitian mothers.
BACKGROUND
Haiti is a country with a heavy burden of HIV infection in childbearing women. Previous studies have shown that early infant deaths are common in children of HIV-infected women. This study was designed to define the rates of and risk factors for systemic bacterial and mycobacterial infection in such children and to identify the causative agents.


METHODS
A cohort of 120 children born to HIV-infected mothers between May 2001 and December 2003 were prospectively observed to 15 months of age. They received comprehensive pediatric care at the GHESKIO Centers. Children were assigned to being HIV-infected by serology, RNA detection, and/or defining clinical illnesses. Blood cultures were obtained before giving antibiotics in children who were febrile or chronically ill. Blood cultures also were obtained at selected visits on well children.


RESULTS
The mortality rate in the first 15 months was high, 22 of 106 (207/1,000 live births) in these children. Sixteen (70%) deaths were within 6 months of birth. Fourty-eight blood cultures had clinically significant organisms of which 38 were Staphylococcus aureus. Blood cultures were more likely to be positive in symptomatic and in HIV-infected children.


CONCLUSIONS
Despite perinatal HIV treatment, mortality in children born to HIV-infected mothers remained high. Bacteremia, particularly with Staphylococcus aureus, is a partial explanation for excess illness.
Noel
Francine
F
GHESKIO Centers, Port-au-Prince, Haiti.
Wright
Peter F
PF
Bois
Gyrlande
G
Deschamps
Marie-Marcelle
MM
de Matteis
Patricia
P
Cassangnol
Rachelle
R
Thimothee
Maryse
M
Celestin
Katucia
K
Vaz
Louise
L
Bradshaw
John A
JA
Brignoli
Emilio
E
Zhu
Yuwei
Y
Johnson
Warren D
WD
Fitzgerald
Daniel
D
Pape
Jean W
JW
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000453:epidemiology / Q000401:mortality*; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D016470:Bacteremia / Q000175:diagnosis / Q000453:epidemiology* / Q000382:microbiology; D015331:Cohort Studies; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000453:epidemiology / Q000276:immunology / Q000635:transmission*; D006205:Haiti / Q000453:epidemiology; D006801:Humans; D018445:Infectious Disease Transmission, Vertical; D011446:Prospective Studies; D015996:Survival Rate
D000900:Anti-Bacterial Agents